India-based startup Bonatra has launched a wearable smart ring, Smart Ring X1, which tracks various health parameters, including heart rate, blood oxygen (SpO₂), and sleep quality.
The device works with the Bonatra app to report the health parameters, it also syncs with continuous glucose monitors (CGMs) to generate a metabolic score.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe wearable technology market has grown in recent years, with Covid-19 propelling market growth. GlobalData estimates the wearable technology market to grow to $156bn by 2024.
Weighing 4g, the Smart Ring X1 is waterproof and made using hypoallergenic titanium alloys to allow for long-term wear. It also connects to the Bonatra app to allow for comprehensive health tracking via a Sleep Score, Readiness Score and Movement Index.
“Over the last year, we have consistently focused on introducing AI-based, IoMT-enabled and doctor-led initiatives to guide people towards achieving their health goals,” said Rahul Kishore Singh, CEO of the India-based start-up.
“The launch of our wearable smart rings is a step in that direction. This wearable technology isn’t just about monitoring health parameters. It’s also about empowering individuals with actionable insights for making positive lifestyle changes.”
The Bonatra app also has a coach-enabled programme that connects users with certified health coaches and doctors to understand and improve their health scores. It also allows for curating personalised health programmes, which are created using AI-based algorithms from the data collected from the ring. The programme is offered as a subscription-based service.
The app also offers personalised programmes for diabetes and polycystic ovarian disease management.
Bonatra previously received Rs55m ($0.67m) in pre-seed funding in November 2022.